𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease

✍ Scribed by C. J. C. Roberts; J. M. Ford; C. A. Truman; M. Scott; P. M. Mäkelä; G. K. Wilcock

Publisher
Springer
Year
1998
Tongue
English
Weight
99 KB
Volume
54
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of tacrine and lecithin in Al
The effect of tacrine and lecithin in Alzheimer's disease
✍ K. Peace; N. H. G. Holford 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 602 KB

Tacrine, a cholinesterase inhibitor, has beneficial effects on cognition and global status in patients with Alzheimer's disease. These effects have been demonstrated in clinical trials by double-blind comparisons with placebo. Tacrine dosages have been studied in 5 protocols that used either enrichm

Assessing response to tacrine using the
Assessing response to tacrine using the factor analytic structure of the Alzheimer's disease assessment scale (Adas)—cognitive subscale
✍ Dr. Jason T. Olin; Lon S. Schneider 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 2 views

A factor analysis of the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADASc), the primary cognitive outcome measure in most clinical trials of drugs for Alzheimer's disease, was undertaken to test whether factor scores are differentially sensitive to change in a placebo-controlled 30-wee

The effects of tacrine on regional cereb
The effects of tacrine on regional cerebral blood flow in Alzheimer's disease
✍ John T. O'Brien; Ghulam M. S. Syed; Professor Raymond Levy 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

Regional cerebral blood flow (rCBF) was studied in nine patients with Alzheimer's disease before and after trestment with tacrine. A small but significant improvement in cognitive functioning on the drug was not accompanied by significant changes in rCBF for the group as a whole. However, when the a

Long-term effects of tacrine in alzheime
Long-term effects of tacrine in alzheimer's disease: An open study
✍ Sarah A. Eagger; Marcus Richards; Professor Raymond Levy 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB 👁 2 views

## Abstract To study the efficacy and safety of prolonged tacrine administration, we monitored 41 patients meeting NINCDS–ADRDA criteria for probable Alzheimer's disease while taking tacrine on an open basis for a period of up to 192 weeks. Dependent variables were the Abbreviated Mental Test Score

Serum levels of tacrine in relation to c
Serum levels of tacrine in relation to clinical response in Alzheimer's disease
✍ Sarah Eagger; Raymond Levy 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB 👁 1 views

## Abstract The relationship between the serum concentrations of tacrine (tetrahydroaminoacridine), two of its metabolites and age, sex and therapeutic effect was examined. The improvement in two measures of cognitive function previously reported to show significant changes with the drug (MMSE and